Zhibin Wu, Lutan Yan, Lin Zhou, Xiaoli Shi, Xiaohui Wang
{"title":"Construction and Validation of a Prediction Model for TACE Resistance in Hepatocellular Carcinoma Based on Contrast-Enhanced Ultrasound Radiomics.","authors":"Zhibin Wu, Lutan Yan, Lin Zhou, Xiaoli Shi, Xiaohui Wang","doi":"10.1093/bjr/tqag281","DOIUrl":"https://doi.org/10.1093/bjr/tqag281","url":null,"abstract":"<p><strong>Objective: </strong>To construct and validate a contrast-enhanced ultrasound (CEUS) radiomics-clinical model for predicting transarterial chemoembolization (TACE) resistance in hepatocellular carcinoma (HCC).</p><p><strong>Methods: </strong>A total of 168 HCC patients who underwent CEUS on two vendor platforms (Philips E9 and GE Logiq E95) were split into a training set (n = 118) and an internal validation set (n = 50), with an additional 80 patients forming an external validation cohort. For each patient, 2D regions of interest were manually delineated on the largest cross-sectional slice of each CEUS phase. Radiomic features were extracted and screened by LASSO regression; the twelve retained features were linearly combined into a single Rad-score. The Rad-score and three prespecified clinical risk factors (tumor size, Child-Pugh class, AFP) confirmed by multivariate analysis were combined into a parsimonious logistic regression (LR) model with four predictors in total. Performance was assessed by ROC curve, calibration curve, decision curve analysis (DCA), subgroup analysis, and prospective validation.</p><p><strong>Results: </strong>The combined model had AUCs of 0.895, 0.891 and 0.846 in three sets, with subgroup AUCs >0.86. Prospective validation showed TACE plus sorafenib improved 6-month response rate from 26.7% to 53.3% for high-risk patients.</p><p><strong>Conclusion: </strong>The CEUS radiomics-clinical model accurately predicts TACE resistance, guiding individualized HCC treatment.</p><p><strong>Advances in knowledge: </strong>This model integrates CEUS multi-phase radiomics and clinical factors, outperforming single clinical/radiomic models. Strict multi-step screening and comprehensive validation avoid data leakage, ensuring robust prediction and clinical translatability.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"CT-based Epicardial Adipose Tissue Change as a Promising Biomarker of Obstructive Coronary Artery Disease Progression: A Longitudinal Observational Study.","authors":"Wenzhuo Zhang, Li Zhang, Manling Chen, Jiayi Fu, Danyan Jin, Xing Xiong, Xinyi Chen, Fandong Zhang, Xiaojun Guan, Qijing Zhou, Xiaojun Xu","doi":"10.1093/bjr/tqag275","DOIUrl":"https://doi.org/10.1093/bjr/tqag275","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the association between CT-based longitudinal changes in epicardial adipose tissue (EAT) volume and obstructive coronary artery disease (CAD) progression.</p><p><strong>Methods: </strong>We included 583 suspected CAD patients (median age, 60 years; 348 men) who underwent coronary CT angiography (CCTA) between June 2010 and June 2017, and received follow-up CCTA at an interval of ≥ 2 years (median interval, 3.33 years; IQR, 2.67 to 4.33 years). 107 patients progressed to obstructive CAD. EAT volume and coronary artery calcium score (CACS) were measured on non-contrast CCTA. Annualised EAT volume change was calculated as the difference between follow-up and baseline scans divided by the follow-up duration. Obstructive CAD progression was defined as new-onset ≥50% stenosis in initially non-obstructive patients. The association of EAT with obstructive CAD progression was evaluated by univariate and multivariate logistic regression.</p><p><strong>Results: </strong>Annualised EAT volume change was 3.47 cm³ in the obstructive progression group and 2.07 cm³ in the no obstructive progression group (P = 0.006). In univariate analysis, only age, CACS, baseline largest luminal diameter stenosis and annualised EAT volume change were significantly associated with obstructive CAD progression. Annualised EAT volume change remained independently associated with obstructive CAD progression (adjusted OR = 1.06, P = 0.007) after adjustment for variables significant in univariate analysis.</p><p><strong>Conclusions: </strong>Annualised EAT volume change was independently associated with obstructive CAD progression.</p><p><strong>Advances in knowledge: </strong>Annualised EAT volume change may represent a CT-based imaging marker of obstructive CAD progression.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frederikke Engel Høi-Hansen, Christian Hinge, Helle Hjorth Johannesen, Elisabeth Albrecht-Beste, Christina Mikkelsen, Sisse Rye Ostrowski, Barbara Malene Fischer, Flemming Littrup Andersen, Kirsten Korsholm
{"title":"Incidental Findings in Asymptomatic Healthy Individuals Screened with Total-Body Ultra-Low-Dose 18F-FDG-PET/Low-Dose CT.","authors":"Frederikke Engel Høi-Hansen, Christian Hinge, Helle Hjorth Johannesen, Elisabeth Albrecht-Beste, Christina Mikkelsen, Sisse Rye Ostrowski, Barbara Malene Fischer, Flemming Littrup Andersen, Kirsten Korsholm","doi":"10.1093/bjr/tqag273","DOIUrl":"https://doi.org/10.1093/bjr/tqag273","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the prevalence and clinical significance of incidental findings (IF) detected by Total-body 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in a genuinely asymptomatic cohort of blood donors.</p><p><strong>Methods: </strong>117 healthy, asymptomatic blood donors underwent ultra-low-dose FDG-PET/low-dose CT. The primary objective was to create an atlas of glucose metabolism in healthy individuals. A secondary objective was to assess the frequency and nature of IF, informing future considerations of the clinical value of potential screening programs. Here we report on IF.</p><p><strong>Results: </strong>IF were detected in 64 participants (55%), with 51 (44%) presenting clinically insignificant IF and 13 (11%) clinically significant IF. Common insignificant IF included benign or inflammatory metabolic activity in the esophagus or lung parenchyma (n = 19), metabolically active reactive lymph nodes (n = 14), and degenerative skeletal changes (n = 13). Clinically significant IF comprised pathologically metabolically active cysts and polyps (n = 8), significantly enlarged vessels (n = 1), suspected malignant tumors (n = 1), large lipomas (n = 1), sarcoidosis (n = 1), and liver steatosis (n = 1).</p><p><strong>Conclusions: </strong>This is the first study to systematically investigate incidental findings in an asymptomatic cohort using ultra-low-dose total-body FDG-PET/CT. Even in this highly selected population, numerous IFs were revealed, underscoring the need for risk-stratified, data-driven screening strategies integrating genetic biomarkers identifying individuals who will truly benefit.</p><p><strong>Advances in knowledge: </strong>This first study of ultra-low-dose total-body FDG-PET/CT in asymptomatic donors found frequent incidental findings (55%, 11% clinically significant), establishing lower-bound estimates and supporting risk-stratified screening approaches.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparative Performance of Contrast-enhanced versus Abbreviated Non-contrast MR Enterography in Crohn Disease Evaluation: a Retrospective Study.","authors":"Arvin Arian, Saeed Mohammadzadeh, Alireza Farahani, Madjid Shakiba, Mahdi Nowruzi, Peyman Kamali Hakim, Sina Delazar, Fahimeh Zeinalkhani","doi":"10.1093/bjr/tqag280","DOIUrl":"https://doi.org/10.1093/bjr/tqag280","url":null,"abstract":"<p><strong>Objectives: </strong>In this study, we compared full protocol MR enterography (including contrast-enhanced images) and modified non-contrast protocol in assessment of CD activity.</p><p><strong>Material and method: </strong>In this retrospective cross-sectional study, we included 182 patients with histologically confirmed CD who underwent MR enterography examination in ANONYMISED. For all patients, CD activity was interpreted by two independents, first based on abbreviated protocol (including T2-weighted imaging and balanced steady-state free precession (b-SSFP)) and then based on full protocol MRI. Agreement was assessed by concordance rates and Cohen's kappa.</p><p><strong>Results: </strong>We found a high inter-modality agreement in CD activity assessment, with abbreviated non-contrast MRE demonstrating 98.4% concordance (179/182 cases) to contrast-enhanced MRE. Discordant findings (1.6%, 3/182) included one case misclassified as fibrostenotic and two as non-specific findings. Inter-reader agreement in MR enterography examination was also high (κ = 0.977 for final diagnosis, κ = 0.969 for fibrostenosis, and κ = 0.978 for comb sign detection), supporting high reproducibility between two radiologists.</p><p><strong>Conclusion: </strong>Our findings demonstrate that abbreviated MR enterography (including T2-weighted sequence and b-SSFP) had substantial agreement with full protocol MR enterography in CD activity assessment, supporting its value as a reliable contrast-free alternative for practicing in clinical centers.</p><p><strong>Advances in knowledge: </strong>Our investigation represents an advancement in CD imaging, leveraged by a large sample size, rigorous methodology, and comprehensive evaluation of different CD characterizations.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Charlotte C I Schneider, Arthur J A T Braat, Sanne M A Jansen, Maaike Dotinga, Kenneth F M Hergaarden, Regina G H Beets-Tan, Tarik R Baetens, Elisabeth G Klompenhouwer, Belinda J de Wit-van der Veen
{"title":"Dosimetry for Radioembolization of Liver Metastases: essential knowledge for Interventional Radiologists.","authors":"Charlotte C I Schneider, Arthur J A T Braat, Sanne M A Jansen, Maaike Dotinga, Kenneth F M Hergaarden, Regina G H Beets-Tan, Tarik R Baetens, Elisabeth G Klompenhouwer, Belinda J de Wit-van der Veen","doi":"10.1093/bjr/tqag282","DOIUrl":"https://doi.org/10.1093/bjr/tqag282","url":null,"abstract":"<p><p>In transarterial radioembolization (TARE) for liver metastases, dosimetry is essential to optimize therapeutic response while minimizing toxicity. Dose planning or pre-treatment dosimetry have evolved from empirical and single-compartment models to multi-compartment approaches, leading to improved tumour response and overall survival. More recently, voxel-based dosimetry has emerged as an advanced technique that provides high-resolution spatial dose mapping. Dose verification or post-treatment dosimetry using post-treatment imaging is essential for establishing dose-response relationships and defining clinically relevant dose thresholds. Even when such thresholds are proposed, their translation into clinical practice is challenging due to the numerous uncertainties introduced throughout the radioembolization workflow. Several physical and biological factors, including the effects of microsphere density remain insufficiently understood, making it difficult to determine their true impact on treatment outcomes. Collectively, these challenges underscore the need for standardized dosimetric methodologies and more robust evidence to enable reliable, personalized dose planning and verification, ultimately improving outcomes and expand the indications of radioembolization for liver metastasis.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mustafa Bilgili, Sinan Karatoprak, Oğuz Aslan, Gamze Türk, Ebru Akay
{"title":"Diagnostic Accuracy and Procedural Efficiency of ACR TI-RADS, EU-TIRADS, and K-TIRADS in ≤ 10 mm Thyroid Nodules Using Bethesda Cytology: A Cohort of 998 Nodules.","authors":"Mustafa Bilgili, Sinan Karatoprak, Oğuz Aslan, Gamze Türk, Ebru Akay","doi":"10.1093/bjr/tqag276","DOIUrl":"https://doi.org/10.1093/bjr/tqag276","url":null,"abstract":"<p><strong>Objectives: </strong>To compare the diagnostic performance and procedural efficiency of American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS), European Thyroid Imaging Reporting and Data System (EU-TIRADS), and Korean Thyroid Imaging Reporting and Data System (K-TIRADS) in ≤ 10 mm nodules using Bethesda cytology as the reference standard.</p><p><strong>Methods: </strong>This retrospective study included 998 nodules ≤10 mm undergoing ultrasound-guided fine-needle aspiration biopsy (FNAB). Primary analyses included Bethesda II (negative) and Bethesda V-VI (positive) nodules excluding Bethesda I/III/IV, yielding 604 nodules (540 negative; 64 positive). Categories 1-3 were considered low risk and 4-5 high risk under a harmonized threshold Diagnostic performance and classification patterns were compared.</p><p><strong>Results: </strong>K-TIRADS showed the numerically highest sensitivity (93.8%) and negative predictive value (NPV) (97.9%), although sensitivity did not differ significantly between systems, with lower specificity (35.4%) and accuracy (41.6%).EU-TIRADS showed intermediate performans (sensitivity 68.8%, specificity 73.7%, accuracy 73.2%). ACR TI-RADS achieved the highest specificity (83.3%) and accuracy (81.0%) with lower sensitivity (60.9%). Low-risk classification rates were 78.6% (ACR), 69.2% (EU), and 32.3% (K) of nodules; false-positive high-risk classifications among Bethesda II nodules were 16.7%, 26.3%, and 64.6%, respectively.</p><p><strong>Conclusion: </strong>In ≤ 10 mm nodules, the three systems demonstrated distinct diagnostic and classification profiles under a harmonized TR4-5 threshold, with different trade-offs between sensitivity and specificity.</p><p><strong>Advances in knowledge: </strong>Applying a harmonized TR4-5 threshold in ≤ 10 mm nodules reveals substantially differences in classification patterns among the three systems, demonstrating that they are not interchangeable under a uniform risk threshold.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149392972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Comprehensive Radiomics Model for Predicting Progression-Free Survival in High-Risk Neuroblastoma Based on CT Imaging.","authors":"Jinrong Li, Sijie Gao, Bao Zhang, Wei Li, Ye Xu","doi":"10.1093/bjr/tqag272","DOIUrl":"https://doi.org/10.1093/bjr/tqag272","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates the predictive utility of clinical features, CT imaging characteristics, radiomic features, and multimodal statistical models in estimating progression-free survival (PFS) in high-risk neuroblastoma (NB) patients.</p><p><strong>Materials and methods: </strong>105 pathologically confirmed high - risk NB patients per COG criteria were retrospectively selected and divided into training (80%) and test sets (20%). Statistical models were built using clinical variables, CT features, and radiomic features, with SVM algorithms employed. Five models were assessed, including radiomics, clinical + CT, clinical + radiomics, imaging + radiomics, and combined clinical + CT + radiomics models. A nomogram was constructed to predict PFS.</p><p><strong>Results: </strong>Univariate analysis found NSE > 200 μg/mL, LDH >1000 U/L, and MYCN amplification as significant poor - prognosis predictors (P < 0.05). Multivariate analysis confirmed MYCN amplification (P = 0.043) and IDRFs presence (P = 0.036) as independent risk factors. A radiomics model was built from CT scans' different phases. The combined model showed the best and most stable performance with AUC values of 0.855, 0.796, 0.856 in training, validation, and test cohorts. A nomogram integrating Rad - Score and clinical parameters from Cox regression was developed, with a C - index of 0.806 (P = 0.028) via bootstrap validation.</p><p><strong>Conclusion: </strong>This study validates a PFS predictive model combining clinical, CT, and radiomic features, providing a robust tool for individualized prognosis in high-risk NB patients.</p><p><strong>Advances in knowledge: </strong>Radiomics demonstrates predictive utility for progression-free survival in pediatric patients with high-risk neuroblastoma.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149392971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H Liu, D Han, M A Heuvelmans, C van der Aalst, J W C Gratama, M Silva, S B Fain, M Oudkerk
{"title":"Comparative Analysis of Visual Emphysema Detection with Low Attenuation Area Quantification: A Systematic Review.","authors":"H Liu, D Han, M A Heuvelmans, C van der Aalst, J W C Gratama, M Silva, S B Fain, M Oudkerk","doi":"10.1093/bjr/tqag269","DOIUrl":"https://doi.org/10.1093/bjr/tqag269","url":null,"abstract":"<p><strong>Objectives: </strong>To systematically review CT-based LAA% for emphysema quantification, explore the application of percentage low attenuation area (LAA% below -950HU), in comparison with visual emphysema scoring.</p><p><strong>Methods: </strong>Following PRISMA-DTA guidelines, searches were conducted (01-01-1972 to 01-04-2026) in PubMed, Embase®, and Web of Science databases to identify English-language studies of adults ≥18 years with CT-quantified emphysema. Two independent readers screened titles, abstracts and full texts against predefined inclusion/exclusion criteria. Studies comparing LAA%-quantified emphysema with visual scores were included.</p><p><strong>Results: </strong>737 studies were reviewed, 5 (0.7%) met the eligibility criteria. These studies originated from Asia, Europe and the United States. LAA% cut-off values for emphysema varied: two studies used a 6% threshold, one used 5%, another used 1.5%, and one applied ordinal severity thresholds from 1% to 25%. Visual classification also differed, with three studies using the Fleischner Society system, one using a modified 3-point score, and another using the Goddard classification. Agreement between visual assessment and LAA%-based quantification was generally poor, with reported kappa values of 0.22 (n = 1,221), -0.06 (n = 200), and 0.48 (n = 98). Two studies further reported agreement based on sensitivity (86.8% and 58.0%) and specificity (84.2% and 39.0%).</p><p><strong>Conclusions: </strong>Based on limited evidence, substantial heterogeneity exists between visual assessment and LAA% quantification in emphysema. Discordance between visual and quantitative CT assessment likely reflects differences in diagnostic criteria and technical characteristics, highlighting the need for standardized reporting and methodology.</p><p><strong>Advances in knowledge: </strong>This systematic review provides a comprehensive comparison of visual scoring and LAA% metrics. It demonstrates limited agreement and substantial methodological heterogeneity of CT assessment of emphysema.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Role of Pancreatic Shear Wave Elastography in Children with Type 1 Diabetes: A Comparative and Correlative Study with Clinical and Laboratory Parameters.","authors":"Akash Rauniyar, Poonam Sherwani, Nowneet Kumar Bhat, Kalyani Sridharan, Ranjeeta Kumari","doi":"10.1093/bjr/tqag270","DOIUrl":"https://doi.org/10.1093/bjr/tqag270","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate pancreatic stiffness in children with type 1 diabetes mellitus (T1DM) using two-dimensional shear wave elastography (2D-SWE), compare findings with age‑matched controls, and assess associations with pancreatic size, clinical parameters, and disease duration.</p><p><strong>Methods: </strong>Seventy‑six children (38 T1DM, 38 controls) aged 5-18 years underwent standardized pancreatic ultrasound with SWE of the head, body, and tail. Three readings per region were averaged. Pancreatic dimensions, fasting blood sugar (FBS), HbA1c, and clinical details were recorded. Group comparisons and correlation analyses were performed.</p><p><strong>Results: </strong>Children with T1DM showed significantly higher stiffness than controls across all regions (p < 0.001). Mean SWE increased with disease duration: recent‑onset 3.11 ± 1.02 kPa, intermediate 4.72 ± 0.88 kPa, long‑standing 6.29 ± 0.81 kPa; controls 2.85 ± 0.31 kPa. Pancreatic size was smaller in diabetics, with progressive reduction correlating with chronicity. SWE showed a strong positive correlation with disease duration (ρ = 0.823, p < 0.001) and an inverse correlation with pancreatic size. No meaningful association was seen between SWE and HbA1c or FBS. ROC analysis demonstrated good discriminatory performance of pancreatic SWE for differentiating children with T1DM from healthy controls.</p><p><strong>Conclusions: </strong>Pancreatic stiffness is increased in children with T1DM and rises progressively with disease duration while pancreatic size declines. SWE reflects long‑term structural change rather than short‑term glycaemic status.</p><p><strong>Advances in knowledge: </strong>This study demonstrates that pancreatic SWE provides quantitative measures of pancreatic stiffness and helps elucidate its associations with pancreatic size and disease duration in children with T1DM.</p>","PeriodicalId":9306,"journal":{"name":"British Journal of Radiology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}